These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17256276)

  • 1. [Pathogenesis of chronic inflammatory bowel diseases].
    Kreisel W
    Praxis (Bern 1994); 2006 Dec; 95(50):1965-73. PubMed ID: 17256276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of genetic, environmental and immune factors in the pathogenesis of inflammatory bowel diseases.
    Chowers Y
    Isr Med Assoc J; 2002 Oct; 4(10):815-7. PubMed ID: 12389349
    [No Abstract]   [Full Text] [Related]  

  • 3. Inflammatory bowel disease: an impaired barrier disease.
    Jäger S; Stange EF; Wehkamp J
    Langenbecks Arch Surg; 2013 Jan; 398(1):1-12. PubMed ID: 23160753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defensin-immunology in inflammatory bowel disease.
    Wehkamp J; Stange EF; Fellermann K
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S137-44. PubMed ID: 20117337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
    Strober W; Asano N; Fuss I; Kitani A; Watanabe T
    Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intestinal microflora and chronic inflammatory bowel diseases].
    Desreumaux P; Colombel JF
    Gastroenterol Clin Biol; 2001 Sep; 25(2 Pt 2):C89-93. PubMed ID: 11787387
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ulcerative colitis and Crohn's disease].
    Matsuoka K; Hibi T
    Nihon Rinsho; 2005 May; 63 Suppl 5():507-11. PubMed ID: 15954400
    [No Abstract]   [Full Text] [Related]  

  • 8. Human defensins in Crohn's disease.
    Wehkamp J; Fellermann K; Stange EF
    Chem Immunol Allergy; 2005; 86():42-54. PubMed ID: 15976487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of translational research in inflammatory bowel disease].
    Abreu MT; Sparrow MP
    Rev Gastroenterol Mex; 2007; 72(2):146-53. PubMed ID: 17966376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease.
    Peyrin-Biroulet L; Chamaillard M
    J Endotoxin Res; 2007; 13(3):135-9. PubMed ID: 17621555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent understanding of IBD pathogenesis: implications for future therapies.
    Kucharzik T; Maaser C; Lügering A; Kagnoff M; Mayer L; Targan S; Domschke W
    Inflamm Bowel Dis; 2006 Nov; 12(11):1068-83. PubMed ID: 17075348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease: past, present, and future.
    Sands BE
    J Gastroenterol; 2007 Jan; 42(1):16-25. PubMed ID: 17322989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
    Sartor RB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases.
    Chassaing B; Darfeuille-Michaud A
    Gastroenterology; 2011 May; 140(6):1720-28. PubMed ID: 21530738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial-host interactions in inflammatory bowel diseases and experimental colitis.
    Sartor RB
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():121-32; discussion 132-7, 251-7. PubMed ID: 19710519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inflammatory bowel diseases: an immunological approach].
    Sepúlveda SE; Beltrán CJ; Peralta A; Rivas P; Rojas N; Figueroa C; Quera R; Hermoso MA
    Rev Med Chil; 2008 Mar; 136(3):367-75. PubMed ID: 18575665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Barrier- and autophagic functions of the intestinal epithelia: role of disturbances in the pathogenesis of Crohn's disease].
    Lapis K
    Orv Hetil; 2010 Oct; 151(40):1645-55. PubMed ID: 20860961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the pathogenesis of Crohn's disease: are they relevant for therapeutic options?
    Vavricka SR; Rogler G
    Swiss Med Wkly; 2009 Sep; 139(37-38):527-34. PubMed ID: 19838869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotics and probiotics in treatment of inflammatory bowel disease.
    Gionchetti P; Rizzello F; Lammers KM; Morselli C; Sollazzi L; Davies S; Tambasco R; Calabrese C; Campieri M
    World J Gastroenterol; 2006 Jun; 12(21):3306-13. PubMed ID: 16733845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory bowel disease: progress and current concepts of etiopathogenesis.
    Scaldaferri F; Fiocchi C
    J Dig Dis; 2007 Nov; 8(4):171-8. PubMed ID: 17970872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.